Subscribe
Sign In
Tag: CBT > Cannabis Schedule
Top Stories
DEA Denies Collusion Allegations Ahead of Cannabis Rescheduling Hearing
The DEA argues that cannabis advocates have no evidence that the agency engaged in unlawful communications with a prohibitionist group.
November 25, 2024
Top Stories
Cannabis Rescheduling Judge Says Hands Tied Behind Back, Can’t Add More Participants
The DEA’s administrative law judge said he was 'not involved in or apprised of' the process the agency utilized to select the participants.
November 22, 2024
Top Stories
Cannabis Rescheduling Judge Authorizes Prohibitionist Group to Respond to Collusion Claims
Smart Approaches to Marijuana was accused of working behind the scenes with the DEA before an administrative law judge hearing was granted.
November 21, 2024
Top Stories
Cannabis Rescheduling Advocates Say DEA Stacked Deck, Colluded With Prohibitionists
An administrative law judge is giving the DEA five days to respond to the allegations—if it wants to—after he already approved the hearing’s participant list.
November 20, 2024
Top Stories
Trump’s Pick for Attorney General Promising for Cannabis Policy, Rescheduling
Matt Gaetz has long supported cannabis reform during his time in the U.S. House, including his position that cannabis should be decontrolled.
November 14, 2024
Top Stories
DEA Names 25 Participants for Cannabis Rescheduling Hearing That’s Now Delayed Until 2025
An administrative law judge issued an order pushing back testimonies until January or February.
November 1, 2024
Top Stories
Kamala Harris Adds ‘Legalize Recreational Marijuana’ to To-Do List
The Democratic presidential candidate included cannabis reform among 14 items on her immediate priority list.
October 25, 2024
Top Stories
Cannabis Rescheduling Won’t Solve Industry Banking Problems, Legal Risks
Bank Secrecy Act obligations and federal anti-money laundering laws would still apply to cannabis under a Schedule III listing, legal expert says.
October 23, 2024
Cannabis Industry Research
Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling
The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.
September 20, 2024
California
Treez Files Summary Judgement in Lawsuit Against Feds Over Cannabis-Related Visa Denial
The federal government claims Treez must show its software developer from India ‘does not aid and abet activities that violate the CSA.’
September 19, 2024
Cannabis Advertising
The Complex Impact of Rescheduling Cannabis on Advertising
The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.
September 17, 2024
Banking Bill Cannabis Industry
Trump Signals Support for Federal Cannabis Rescheduling, Banking Reform
The GOP presidential candidate said he will focus on unlocking the ‘medical uses of marijuana to a Schedule 3 drug’ if elected in November.
September 9, 2024
Page 1 of 8
Next Page